Prospective and retrospective clinico-pathological study of autoimmune gastritis
Not Applicable
Recruiting
- Conditions
- Autoimmune gastritis
- Registration Number
- JPRN-UMIN000033610
- Lead Sponsor
- Kakogawa Central City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who are prescribed proton pomp inhibitor or vonoprazan fumarate or who are enabled to discontinue the drugs earlier than 1 month before endoscopic examination.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endoscopic findings, Pathological findings, titer of anti-parietal cell antibody, existence of anti-intrinsic factor antibody and existence of Helicobacter pylori infection at the first diagnose establishment year and 1 year, 2 years, 3 years, 4 years and 5 years after the first year
- Secondary Outcome Measures
Name Time Method Existence of accompanied diseases: neuroendocrine cell tumor, gastric cancer, anemia, autoimmune diseases (thyroid diseases, Type1 diabetes, Sjogren's syndrome and other autoimmune diseases), pepsinogen (PG) 1, PG 2 and PG 1/2 at the first diagnose establishment year and 1 year, 2 years, 3 years, 4 years and 5 years after the first year